Eugenia Leeds
Investor Relator
Replay available
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF) Q2 2025 Earnings Call
Recordati Industria Chimica e Farmaceutica S.p.A. (OTC: RCDTF) Q2 2025 earnings conference call, held 2025-07-30. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Rob Cormans
Chief Executive Officer
Luigi Licorte
Chief Financial Officer
Alberto Martinez
Executive Vice President of Specialty and Primary Care
Scott Pescatore
Executive Vice President of Rare Diseases
Milan Droskovic
Executive Vice President of R&D
Sophia Graf
Analyst, GPL
Alistair Campbell
Analyst, World Bank Canada
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Recordati S.p.a..
Replay transcript excerpt
WEBVTT 00:00:00.689 -- 00:00:03.513 Good afternoon. This is the conference call operator. 00:00:03.513 -- 00:00:08.160 Welcome. Thank you for joining the Recordati First Half 2025 presentation conference 00:00:08.160 -- 00:00:12.346 call. As a reminder, all participants are in listening mode. 00:00:12.346 -- 00:00:16.131 After the presentation, there will be an opportunity to ask questions by pressing star 00:00:16.131 -- 00:00:18.395 1 at any time. 00:00:18.395 -- 00:00:22.180 Should anyone need assistance due to the conference call, you may signal an operator 00:00:22.180 -- 00:00:27.087 by pressing star and 0 on the table. At this time, I would like to turn the conference 00:00:27.087 -- 00:00:32.046 over to Eugenia Leeds, Investor Relator. Please go ahead, madam. 00:00:32.046 -- 00:00:36.833 Thank you, and good afternoon, everyone. I'm pleased to be here today with Rob Cormans, 00:00:36.833 -- 00:00:41.860 our CEO, and Luigi Licorte, our CFO. Together, they will present results for 00:00:41.860 -- 00:00:44.203 the first half of 2025. 00:00:44.203 -- 00:00:48.910 Also joining for the Q&A session will be Alberto Martinez, Executive Vice President of 00:00:48.910 -- 00:00:54.697 Specialty and Primary Care, Scott Pescatore, Executive Vice President of Rare Diseases, 00:00:54.697 -- 00:00:58.721 and Milan Droskovic, Executive Vice President of R&D. 00:00:58.721 -- 00:01:03.527 As always, the presentation is available in the Investors section of our website. 00:01:03.527 -- 00:01:06.350 It is now my pleasure to pass the call over to Rob. 00:01:06.350 -- 00:01:08.713 Please go ahead. 00:01:08.713 -- 00:01:13.318 Thank you, Eugenia, and good afternoon, and thank you for joining us today. 00:01:13.318 -- 00:01:18.662 We are very pleased to share our good results for the f...